Synthesis of Auger electron-emitting radiopharmaceuticals

Area of Science:

• Radiochemistry
• Nuclear Medicine
• Oncology

Background:

• Targeted radiotherapy utilizes Auger electron-emitting pharmaceuticals.
• Auger electrons deposit energy locally, minimizing damage to healthy cells.
• Challenges include radionuclide selection, synthesis, and targeted delivery.

Purpose of the Study:

• To review the synthesis of Auger electron-emitting radiopharmaceuticals.
• To cover agents with potential for Auger therapy.
• To discuss major classes of agents developed over the past decade.

Main Methods:

• Literature review of radiopharmaceutical synthesis.
• Focus on agents prepared in the last 10 years.
• Categorization of agents into major classes.

Main Results:

• Synthesis strategies for Auger electron-emitting radiopharmaceuticals are presented.
• Hormone receptor ligands, nucleoside analogs, and intercalating agents are discussed.
• Potential applications of these agents in targeted therapy are highlighted.

Conclusions:

• Efficient synthesis and selective delivery are crucial for Auger electron therapy.
• Various classes of radiopharmaceuticals show promise for Auger therapy.
• Continued research in synthesis and targeting is essential for clinical translation.